Updates in the management of brain(leptomeningeal) metastasis of lung cancer  

作　　者：Ziyi Sun Yuan Chen 

机构地区：[1]Department of Oncology,Tongji Hospital,Tongji Medical College of Huazhong University of Science and Technology [2]Department of Oncology,Taikang Tongji(Wuhan) Hospital

出　　处：《Oncology and Translational Medicine》2018年第4期144-150,共7页肿瘤学与转化医学（英文版）

摘　　要：Brain(leptomeningeal) metastasis is one of the most common and severe complications of lung cancer. This article interprets expert consensus on the treatment advice for brain(leptomeningeal) metastasis of lung cancer, expounding on its epidemiology, diagnostic standards, efficacy assessment, treatment advice, and other aspects.Brain （leptomeningeal） metastasis is one of the most common and severe complications of lung cancer. This article interprets expert consensus on the treatment advice for brain （leptomeningeal） metastasis of lung cancer, expounding on its epidemiology, diagnostic standards, efficacy assessment, treatment advice, and other aspects.

关 键 词：brain （leptomeningeal） metastasis non-small cell lung cancer （NSCLC） chemotherapy epidermal growth factor receptor （EGFR） - tyrosine kinase inhibitor （TKI） whole brain radiotherapy （VVBRT） 

分 类 号：R734.2[医药卫生—肿瘤]